RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > In Focus: User Fees

In Focus: User Fees

Posted 01 February 2008

User fees, the monetary charges that the pharmaceutical, biologic and medical device industries pay for review of marketing applications and associated initiatives such as inspections and for manufacturing establishments have been around for some time. This issue of Regulatory Affairs Focus examines the global similarities and differences in how and for what purpose user fees are assessed in various regulatory jurisdictions.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.